Revenue: INR1,845 million, 26% year-on-year growth, 1% decrease quarter-on-quarter. EBITDA: INR601 million, 42% increase year-on-year, 6% increase quarter-on-quarter. EBITDA Margin: 33% for the ...

Earnings call Advanced Enzyme Technologies reported FY25 revenue growth of 2% YoY and Q4 revenue up 6% YoY. EBITDA margins compressed to 27% in Q4 due to product mix and inventory adjustments.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Rasika Rathi is a highly accomplished lawyer and board member of Specialty Enzymes & Probiotics, a group company of Advanced Enzyme Technologies. In her current role as general counsel of Advanced ...

* Seeks members' nod to approve related party transaction with JC Biotech Private Limited‍ Source text: Further company coverage: Sign up here. Macro Matterscategory Fed's rate cut revives small ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.